We are live on
!
Find out more
NARI
Inari Medical, Inc. Common Stock
NARI
NARI
Delisted
NARI was delisted on the 18th of February, 2025.
202 hedge funds and large institutions have $2.7B invested in Inari Medical, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 51 funds opening new positions, 81 increasing their positions, 44 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
84% more repeat investments, than reductions
Existing positions increased: 81 | Existing positions reduced: 44
57% more call options, than puts
Call options by funds: $15.2M | Put options by funds: $9.66M
50% more first-time investments, than exits
New positions opened: 51 | Existing positions closed: 34
9% more funds holding
Funds holding: 185 → 202 (+17)
4% more capital invested
Capital invested by funds: $2.6B → $2.7B (+$95.5M)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
202
Holders Change
+17
Holders Change %
+9.19%
% of All Funds
3.52%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
51
Increased
81
Reduced
44
Closed
34
Calls
$15.2M
Puts
$9.66M
Net Calls
+$5.52M
Net Calls Change
+$7.76M
Top Buyers
| 1 |
BlackRock
New York
|
+$67.9M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$65.9M |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$60.9M |
| 4 |
DCP
Darsana Capital Partners
New York
|
+$42.2M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$42M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$34.7M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$26.1M |
| 3 |
CCM
CAAS Capital Management
New York
|
-$25.8M |
| 4 |
PA
Perceptive Advisors
New York
|
-$24.7M |
| 5 |
JP Morgan Chase
New York
|
-$22.1M |
